Covered recipient · General Payments record
TERESA CHAVEZ
Allopathic & Osteopathic Physicians Internal Medicine Rheumatology
General Payments · PY2019–2025
$1,422.98
- Reported across 62 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $687.72 | 31 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $268.18 | 12 |
| Corcept Therapeutics | $59.87 | 3 |
| Lilly USA, LLC | $49.20 | 3 |
| Novo Nordisk AS | $43.92 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.01 | 1 |
| Radius Health, Inc. | $32.37 | 1 |
| GENZYME CORPORATION | $30.99 | 1 |
| Abbott Laboratories | $24.42 | 1 |
| MannKind Corporation | $24.22 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $22.39 | 1 |
| DEXCOM, INC. | $21.91 | 1 |
| Amgen Inc. | $21.28 | 1 |
| Exact Sciences Corporation | $20.19 | 1 |
| Insulet Corporation | $19.34 | 1 |
| Sumitomo Pharma America, Inc. | $15.43 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $24.42 | 12/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241004178 | CMS |
| ABBVIE INC. | $14.91 | 02/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640587 | CMS |
| ABBVIE INC. | $13.26 | 04/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640589 | CMS |
| ABBVIE INC. | $27.08 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640591 | CMS |
| ABBVIE INC. | $24.74 | 05/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640593 | CMS |
| ABBVIE INC. | $25.73 | 07/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640595 | CMS |
| ABBVIE INC. | $29.21 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640597 | CMS |
| ABBVIE INC. | $8.88 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640599 | CMS |
| ABBVIE INC. | $27.17 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640601 | CMS |
| ABBVIE INC. | $22.86 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640603 | CMS |
| ABBVIE INC. | $29.62 | 09/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640605 | CMS |
| ABBVIE INC. | $18.34 | 10/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640607 | CMS |
| ABBVIE INC. | $26.38 | 11/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201640609 | CMS |
| Amgen Inc. | $21.28 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228546380 | CMS |
| Corcept Therapeutics | $16.38 | 01/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214210358 | CMS |
| Corcept Therapeutics | $21.98 | 01/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214210380 | CMS |
| Corcept Therapeutics | $21.51 | 05/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214210445 | CMS |
| Dexcom, Inc. | $21.91 | 05/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250533239 | CMS |
| Exact Sciences Corporation | $20.19 | 01/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235650040 | CMS |
| GENZYME CORPORATION | $30.99 | 03/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1233266466 | CMS |
| Insulet Corporation | $19.34 | 07/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207103282 | CMS |
| Lilly USA, LLC | $15.84 | 04/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186893925 | CMS |
| Lilly USA, LLC | $17.51 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186914822 | CMS |
| Lilly USA, LLC | $15.85 | 06/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186867267 | CMS |
| Mannkind Corporation | $24.22 | 03/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1250871539 | CMS |
| Novo Nordisk Inc | $14.17 | 04/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188916482 | CMS |
| Novo Nordisk Inc | $29.75 | 11/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189107332 | CMS |
| Radius Health, Inc. | $32.37 | 03/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249525026 | CMS |
| RECORDATI_RARE_DISEASES_INC. | $22.39 | 05/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1181713784 | CMS |
| Sumitomo Pharma America, Inc. | $15.43 | 08/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176621878 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $34.01 | 11/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223932969 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.